No trend-driven recommendations
Novo launched the pill in the US in January 2026 after winning FDA approval in December 2025, giving it a significant head start in what analysts expect to be a $150bn-a-year market within a decade
On average, GFR decreased during QSYMIA treatment and returned to baseline within 4 weeks after discontinuing QSYMIA [see Warnings and Precautions (5.8)]
Conversely, symptoms of hyperthyroidismsuch as anxiety, tremor, palpitations, heat intolerance, or diarrheawarrant evaluation, as they might indicate excessive thyroid hormone replacement
Prescription Medications For more severe or persistent nausea, a healthcare provider might prescribe stronger anti-nausea medications
Yes, vitamin B12 deficiency is a well-recognised cause of peripheral neuropathy and tingling